# C_2010102EN.01001801.xml

| 21.4.2010 | EN | Official Journal of the European Union | C 102/18 |
| --- | --- | --- | --- |

21.4.2010

EN

Official Journal of the European Union

C 102/18

---

Prior notification of a concentration

(Case COMP/M.5805 — 3i/Vedici Groupe)

(Text with EEA relevance)

2010/C 102/04

| 1. | On 14 April 2010, the Commission received notification, pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1), of a proposed concentration by which the group 3i (‘3i’, United Kingdom), through the company 3i Group plc (‘3i Group’) and certain funds managed by 3i Investments plc (‘3i Investments’), would acquire, within the meaning of Article 3(1)(b) of the Regulation, control of the whole of Vedici Groupe SAS (‘Vedici’, France) by way of purchase of shares. |
| --- | --- |

1.

On 14 April 2010, the Commission received notification, pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1), of a proposed concentration by which the group 3i (‘3i’, United Kingdom), through the company 3i Group plc (‘3i Group’) and certain funds managed by 3i Investments plc (‘3i Investments’), would acquire, within the meaning of Article 3(1)(b) of the Regulation, control of the whole of Vedici Groupe SAS (‘Vedici’, France) by way of purchase of shares.

1

| 2. | The business activities of the undertakings concerned are:






  — | 3i: investment on an international scale in various industrial and service sectors such as engineering, IT services, food, energy and health. As regards investment in health services in France, 3i controls the company Labco SAS, which supplies bio-clinical analysis services in France, |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

3i: investment on an international scale in various industrial and service sectors such as engineering, IT services, food, energy and health. As regards investment in health services in France, 3i controls the company Labco SAS, which supplies bio-clinical analysis services in France,

| — | Vedici: management of private health establishments in France. |
| --- | --- |

—

Vedici: management of private health establishments in France.

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope the EC Merger Regulation. However, the final decision on this point is reserved. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope the EC Merger Regulation. However, the final decision on this point is reserved.

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by e-mail to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number COMP/M.5805 — 3i/Vedici Groupe, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition |
| Merger Registry |
| J-70 |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by e-mail to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number COMP/M.5805 — 3i/Vedici Groupe, to the following address:

European Commission

Directorate-General for Competition

Merger Registry

J-70

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘EC Merger Regulation’).

1

---